CPHI Barcelona announces the winners of the prestigious 2023 CPHI Pharma Awards. The awards recognise outstanding achievements and contributions from the global pharma industry and supply chain across 12 wide-ranging categories.

Enrico Zodio, CEO of Procos, stood out as the clear winner in one of the most coveted prizes – CEO of the Year – for spearheading the company’s impressive development and growth. Procos now turns over in excess of €200 million, having invested in capacity to further increase production, it is among an elite class of CDMOs globally.

In the API Development category, Snapdragon Chemistry (a Cambrex company) was selected as the winner for the development of an ultra-high temperature (>300 °C) continuous flow manufacturing process for racemization of sotorsib (LUMAKRASTM) P-dione. This innovative approach harnessing greener technology resulted in a 58% reduction of PMI (process mass intensity).

Moving on to Finished Formulation, the judges selected Lubrizol Life Science Health for the development and launch of the first solubility-enhancing excipient to be specifically designed for parenteral use in over 20 years. Comprised of building blocks naturally occurring in the body, Apisolex is a poly(amino acid)-based excipient that provides formulators with methods to enhance the solubility of hydrophobic BCS Class II and IV APIs, by up to 50,000-fold.

A manufacturing platform, developed by Luminary Therapeutics, that aims to bring allogeneic cell therapies into the marketplace for under $10,000 was the stand-out entry in the Manufacturing Excellence category. Its Gamma Delta 2.0+ platform does not sacrifice function and will help open up patient access to these life changing therapies.

Gasporox took the honours in the Packaging & Machinery section for its AutoMAP™ Pharma gas measurement system for high or low concentrations of O2 in modified atmosphere packaging. With the updated EU-Annex 1 "Manufacture of Sterile Medicinal Products" explicitly focusing on the quality of small volume and large volume parenterals, AutoMAP™ Pharma’s approach allows the use of the precise laser technology to inspect all different sizes of IV bags, using non-destructive headspace analysis.